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ABSTRACT 
Objectives 
To investigate the effect of a change in second hand smoke (SHS) exposure on heart rate 
variability (HRV) and pulse wave velocity (PWV), this study utilized a quasi-
experimental setting when a smoking ban was introduced. 
Methods 
HRV, a quantitative marker of autonomic activity of the nervous system, and PWV, a 
marker of arterial stiffness, were measured in 55 non-smoking hospitality workers before 
and 3 to 12 months after a smoking ban and compared to a control group that did not 
experience an exposure change. SHS exposure was determined with a nicotine specific 
badge and expressed as inhaled cigarette equivalents per day (CE/d). 
Results 
PWV and HRV parameters significantly changed in a dose dependent manner in the 
intervention group compared to the control group. A one CE/d decrease was associated 
with a 2.3% (95% CI: 0.2, 4.4; p=0.031) higher root mean square of successive 
differences (RMSSD), a 5.7 % (95% CI: 0.9, 10.2; p=0.02) higher high frequency 
component and a 0.72% (95 % CI: 0.40-1.05; p<0.001) lower PWV.  
Conclusions 
PWV and HRV significantly improved after introducing smoke-free workplaces 
indicating a decreased cardiovascular risk.
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INTRODUCTION 
Several epidemiological studies from various countries have shown the beneficial effects 
of a public indoor smoking ban on cardiovascular health, especially acute myocardial 
infarction (AMI). In Indiana, USA, hospital admission rates for AMI declined by 50% 
primarily among non-smokers (Seo and Torabi 2007). In Helena, Montana rates 
decreased by 40%, but returned to former levels after ban suspension (Sargent et al. 
2004), while decreased levels stayed low in Pueblo County after a longer enforcement 
period (Bartecchi et al. 2006). Studies in European cities suggest less pronounced 
decreases (Goodman et al. 2009). In Scotland, AMI rates decreased by 17% after the ban 
compared to a 4% decrease in England that did not have a ban (Pell et al. 2008). A recent 
meta-analysis including 45 studies calculated significantly lower hospital admission rates 
for both coronary events (RR: 0.848; 95% CI: 0.816-0.881) as well as for other heart 
diseases (RR: 0.610; 95% CI: 0.440-0.847) after introducing a comprehensive smoking 
ban (Tan and Glantz 2012). However, most studies lack a control group as well as exact 
information on smoking status and exposure because they were conducted on a 
population level only. To assess the mechanistic public health impact of public smoking 
bans, population-based, sensitive measures beyond AMI are needed. 
Heart rate variability (HRV) is a quantitative marker of autonomic activity of the nervous 
system and lower HRV is associated with higher cardiovascular morbidity and mortality 
(Heart rate variability. Standards of measurement, physiological interpretation, and 
clinical use. Task Force of the European Society of Cardiology and the North American 
Society of Pacing and Electrophysiology.  1996). The main influencing factors are sex, 
age, physical activity, blood pressure and smoking status (Felber Dietrich et al. 2006). In 
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a study by Pope et al., acute exposure to SHS alternating with non-exposed periods led to 
consistently lower HRV measures during exposure (Pope et al. 2001). A cross-sectional 
analysis showed that long-term SHS exposed persons for >2h/day have higher High 
Frequency (HF), lower total power (TP), Low Frequency (LF) and a lower LF/HF ratio 
than unexposed people (Felber Dietrich et al. 2007) . These are important frequency-
domain HRV measures providing further insight on fluctuations of HR (Bilchick and 
Berger 2006). Chen et al. showed that HRV was lower in mice during and after exposure 
to second-hand smoke (SHS) (Chen et al. 2008). No longitudinal study on long-term SHS 
exposure and HRV has been conducted so far. 
Pulse wave velocity (PWV) provides a measure of arterial stiffness (Vlachopoulos et al. 
2010) which is an important indicator of cardiovascular risk and atherosclerosis 
(McEniery and Cockcroft 2007). In addition arterial stiffness is a powerful predictor of 
all-cause mortality (Vlachopoulos et al. 2010; Vlachopoulos et al. 2012). An increase of 
PWV was observed after acute exposure to SHS (Barnoya and Glantz 2005) and after 
smoking one cigarette (Kubozono et al. 2011). Arteries such as the aorta and the femoral 
artery are composed of different amounts of smooth muscle cell layers and acute changes 
in arterial stiffness may reflect changes in arterial tone due to autonomic innervation or 
changes in endothelial function (Hill 2013). 
In another study PWV was found to be higher among smokers than non-smokers but 
smoking cessation did not lead to any significant changes (Yu-Jie et al. 2013). A 
prospective cohort study found a significant relationship between the number of 
cigarettes smoked per day and the annual rate of change in PWV (Tomiyama et al. 2010). 
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Long-term exposure to SHS and its impact on arterial stiffness have not been examined 
as yet. 
When Switzerland introduced a smoking ban in May 2010, the national law left room for 
exceptions (Roosli and Rajkumar 2013). While several cantons – administrative zones in 
Switzerland - completely banned smoking venues and rooms, in other cantons either 
small smoking venues or separated smoking rooms were still allowed. This unique 
situation served as a quasi-experimental setting for our prospective study. The aim was to 
directly relate SHS exposure in non-smoking hospitality workers before and after 
introduction of the smoking ban to HRV and arterial stiffness. We further compared 
possible changes in the intervention group which was subject to the introduction of  
smoke free workplaces to the control group that did not experience any changes in SHS 
exposure at the work place. 
 
METHODS 
 
Study population 
This is a quasi-experimental  study comparing non-smoking employees for whom second 
hand smoke exposure at work was eliminated as a result of the new smoking regulations 
(intervention group) with non-smoking employees that did not undergo any change in 
exposure (control groups). The intervention group consisted of participants who had 
worked for at least 1 year in venues where smoking was either partially or completely 
allowed prior to the introduction of the smoking ban (n=55). After introduction of the 
smoking ban, the intervention group was no longer exposed to SHS at work. The control 
group consisted of individuals who were exposed to SHS both before and after the 
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implementation of the smoking ban because of the exceptional rules described above 
(n=7) and non-smokers that were regularly exposed to SHS at work or in private without 
being employed in the hospitality sector (n=16). Due to difficulties in recruitment of non-
smoking hospitality workers, we additionally included a supplementary group of 14 non-
smoking hospitality workers at baseline, who worked in a smoke-free environment at all 
times (labelled supplementary group).  
In the intervention group, a baseline examination was conducted within the 3 months 
prior to the introduction of the smoking ban. Subsequently, two follow-up examinations 
were conducted at 3-6 months and 9-12 months after the smoking ban introduction. The 
unexposed study participants constituting the supplementary group were examined once; 
all others were invited for examinations three times. Intervals between examinations were 
also about six months.  
Recruitment procedure 
A list of hospitality venues in the cantons of Zurich, Basel City and Basel County was 
created using the digital Swiss phonebook from 2009. Each venue received a letter that 
was followed-up by a phone call and a visit two weeks later.  
Screening questionnaires were distributed to the waiting staff, for providing information 
on the eligibility criteria which were being between 18 and 65 years of age, working at 
least half-time, having worked for at least one year in the hospitality sector and having 
been a non-smoker for at least 5 years. Eligible study participants were invited to a health 
examination, which was carried out in one of the two study centres in Basel City and 
Zurich.  
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The non-hospitality workers were recruited by means of an online advertisement looking 
for non-smokers that were exposed to SHS on a regular basis, either privately or at work.  
Health examinations 
The health examinations comprised cardiovascular and respiratory tests as well as a 
computer-based interview. About 20 minutes into the health examination, 
electrocardiograms (ECG) were continuously recorded for 10 minutes with a 7-lead 
digital recorder (SEER Light, GE Healthcare, Freiburg, Germany) with participants in the 
supine position. ECGs were stored and subsequently analysed on a PC MARS 
workstation (GE Healthcare). Beat annotations were automatically assigned by the GE 
software and manually reviewed by an investigator blinded to the exposure status of 
participants to ensure proper annotation of non-sinus beats and artefacts. Only normal 
sinus beats were used in the calculation of HRV metrics. The duration between the R 
waves of consecutive normal sinus beats (N-N intervals) was identiﬁed and only beats 
with an N-N interval between 0.4 and 2.0 s and ratio between 0.8 and 1.2 were included 
in the analysis. 
Calculations for time domain [standard deviation of N-N intervals (SDNN); square root 
of the mean squared differences of successive N-N intervals (rMSSD)] and frequency 
domain [low-frequency (LF) power (0.04-0.15 Hz), high-frequency (HF) power (0.04-
0.15 Hz), and their ratio (LF/HF)] HRV parameters were evaluated on non-overlapping 
5-min intervals of ECG data using standard techniques (Task Force of the European 
Society of Cardiology 1996). Only 5 minute intervals with a ratio of N-N/R-R intervals 
>90% were included in our analyses.  
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Subsequently, PWV and blood pressure were measured using a VaSera VS-1500N device 
(Fukuda Denshi Co., Tokyo, Japan). Participants were in supine position and at rest for at 
least 10 minutes beforehand. If the first two measures were more than 0.5 m/s apart, a 
third measurement was taken. For analysis the average of the two more similar 
measurements was used. 
Exposure measurements 
SHS was measured using newly developed MONIC passive sampling badges made of 
glass fibre. The amount of nicotine on a badge was determined by gas chromatography 
and used to calculate the number of passively smoked cigarettes(CEs)/day assuming a 
nicotine content of 0.2 mg/cigarette and an average ventilation rate of 10 L/min (Huynh 
et al. 2008),(Durham et al. 2011). 
In the hospitality venues that agreed to participate, at least one MoNIC badge was placed 
for one week, often near the bar where waiting personnel spend much of their working 
time. We calculated for each hospitality worker a time-weighted average workplace 
exposure (Rajkumar et al. 2013) by multiplying their average workplace concentration by 
their workload (in percentage of full time equivalent) and by 0.6, which  represents 
presence time at the work place including  holidays and considering the fact that nicotine 
levels decrease when a venue is  unattended(Rajkumar et al. 2013). . For non-hospitality 
workers average SHS exposure was obtained from a personal badge that participants 
wore on themselves at work and in private on a typical day. 
Statistical Analysis 
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Longitudinal analyses were conducted with two statistical approaches. First, for the 
intervention group and the control group a pre/post ban exposure variable was derived by 
defining baseline data of both groups as pre-ban and the two follow-up examinations as 
post ban although in the control group no ban was introduced. In order to increase 
statistical power we did not differentiate between the follow-up examinations and 
calculated an overall effect. For each outcome a linear mixed effects model with a 
random subject intercept was fit including a study group by pre/post ban interaction term. 
HRV analyses were adjusted for age, sex, BMI and season, PWV additionally for time of 
day and systolic blood pressure as continuous variables. Systolic blood pressure was 
adjusted for age, sex, BMI, season and self-reported asthma. Finally, we calculated crude 
and adjusted values of the health outcomes prior and after the ban for both groups. 
Secondly, covariate-adjusted exposure response associations were calculated with a 
random intercept model using the estimated work place SHS exposure at the time of each 
health examination as explanatory variable using data from all study participants, 
including the unexposed supplementary group.  
Data were analysed using Stata 10.1 (StataCorp LP, College Station, TX). 
RESULTS 
Exposure of the study population 
Our study sample comprised 92 participants, 55 in the intervention group, 23 in the 
control group and 14 in the supplementary group. Groups did not differ in terms of 
sociodemographic factors or health status, except for age, self-reported asthma and 
physical activity (Table 1). There were no diabetics in our sample. Average exposure in 
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the intervention group at baseline was 2.56 (95% CI: 1.70 to 3.44) cigarette equivalents 
per day (CE/day) and 0.16 (95% CI: 0.13 to 0.20) CE/day at follow-up resulting in an 
exposure reduction of 2.40 CE/day (Table 1). In the exposed control group exposure at 
baseline was 2.07 (95% CI: 0.96-3.18) ) CE/day and 1.59 (95% CI: 0.67-2.50) CE/day at 
follow-up.  
Heart Rate Variability 
From the HRV analyses 2 observations from the intervention group and 5 from the 
control group were excluded due to missing data (n=1) or insufficient quality (n=6). At 
baseline, adjusted HRV parameters did not differ between the intervention and the 
exposed control group (Table 2). After the introduction of the smoking ban, SDNN, 
RMSSD, HF, LF/HF and Total Power significantly diverge between the two groups 
(Figure 1). All these parameters increase in the intervention group while decreasing in the 
control group except the LF/HF ratio which goes in the opposite direction, leading to a 
significant change in the intervention group relative to the exposed control group after 
implementation of the smoking ban. The exposure-response model (Table 3) shows 
significant increases of 2.3% (95% CI: 0.2 to 4.4; p=0.031) and 5.7 % (95% CI: 0.9 to 
10.2; p=0.02) per decrease in CE/day for RMSSD and HF, respectively. SDNN and Total 
Power are associated with an increase of 1.8 % (95% CI: -0.1 to 3.8; p=0.069) and 4.1% 
(95% CI: 0.0 to 8.0; p=0.51), while the LF/HF ratio significantly decreases by -5.7% 
(95% CI: -9.1 to -2.4); p=0.001) per decrease in CE/day. LF does not change materially. 
For comparison, age-dependent changes in HRV parameters obtained from the same 
model are shown in table 3. 
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Pulse Wave Velocity 
For the arterial stiffness analyses two participants had missing data and technical 
problems resulted in the loss of five observations for the PWV measurements (4 
intervention, 1 control). Table 2 shows crude and adjusted values of PWV for the 
intervention and control group. Figure 2 illustrates the changes in adjusted values 
comparing the intervention and control groups. Differences in PWV are not significant 
although the intervention group shows a steady decrease over the year, an effect not 
observed in the control group. Systolic blood pressure decreases in the intervention group 
and increases in the control group. 
According to the exposure-response model (Table 3) PWV declines with each CE/day 
decrease by 0.72% (95% CI: 0.40 to 1.05; p<0.001) whereas the decrease for systolic 
blood pressure is not statistically significant.  
DISCUSSION 
The smoking ban implementation led to statistically significant improvements in HRV 
parameters in non-smoking hospitality workers within 12 months. HRV increased in the 
intervention group and PWV decreased compared to the control group that did not 
experience any changes in SHS exposure.  
This study addresses several research gaps that the Institute of Medicine 2010 report on 
SHS exposure and cardiovascular effects identified (Secondhand Smoke Exposure and 
Cardiovascular Effects: Making Sense of the Evidence  2010): It directly examines the 
exposure-response relationship of individual-level SHS exposure to HRV and arterial 
stiffness and accounts for potential confounders, including other risk factors for 
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cardiovascular events. It also compares possible changes in an intervention group where 
smoke free workplaces were introduced to a control group that did not experience a 
change in SHS exposure. 
Comparison with the literature 
Our results on HRV are in line with the only other study looking into long-term effects of 
SHS on HRV  reporting trends of lower levels in SDNN, Total Power and HF in subjects 
that were exposed to SHS for >2h/d compared to unexposed subjects in a cross-sectional 
setting (Felber Dietrich et al. 2007). Our findings are also supported by other studies that 
looked at acute effects of SHS on HRV and found consistent decreases in SDNN as soon 
as subjects were exposed (Pope et al. 2001) or right after exposure (Zhang et al. 2013; 
Wilson et al. 2010). The effect of active smoking on heart rate variability has been 
studied extensively. While several studies found diminished HRV in heavy smokers 
(Barutcu et al. 2005; Levin et al. 1992; Hayano et al. 1990), others did not confirm this 
(Kageyama et al. 1997; Murata et al. 1992). A study examining the effect of smoking 
cessation on HRV recorded a significant increase one day after cessation in heavy 
smokers, that although diminished, persisted one month after cessation (Yotsukura et al. 
1998). This effect is in line with another study looking at regular smokers (Minami et al. 
1999).  
Interpretation of our results 
No significant difference in HRV parameters between the intervention and the exposed 
control group could be detected at baseline. SDNN, reflecting the overall variability of 
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HRV, increased by 1.8% per decrease in CE/day, which is more than the 1.5% decrease 
of SDNN per year of life according to the same exposure-response model. Applying the 
average exposure reduction of 2.4 CEs/day that we estimated in this study, this effect 
corresponds to a delay of roughly three years in HRV reduction. RMSSD and HF 
describing parasympathetic activity both increased significantly. LF did not change 
measurably while the LF/HF ratio significantly decreased. These alterations support 
former published evidence suggesting that passive smoking increases the sympathetic 
drive and reduces parasympathetic modulation as well as overall HRV (Dinas et al. 
2013). 
PWV was higher at baseline in the intervention group than in the exposed control group. 
During the study the two groups drew closer together although the ban effect was not 
significant. In the exposure-response model, PWV significantly declined by 0.72% per 
decrease in CE/day, which corresponds to a ban effect of about 2.5 years of life. The 
somewhat discordant result of the exposure-response model compared to the pre/post 
model means that PWV was strongly correlated with SHS exposure at the workplace but 
changes within 1 year were small. This pattern would be consistent with a more chronic 
effect of SHS assuming that measured exposure at the workplace at baseline is 
representative for chronic exposure. 
Strengths and limitations 
To the best of our knowledge this is the first study to prospectively measure the effect of 
a smoking ban on subclinical outcomes related to cardiovascular physiology. A major 
asset of this study is the quasi experimental setting that allowed comparing the effects in 
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workers where a smoke free workplace was introduced to a control group without an 
exposure change. A further strength is that exposure data was collected at the same time 
as the health outcomes. A prospective study avoids the dangers of a possible recall bias 
and mixed linear models allow for within-subject clustering. By using the MoNIC badge, 
SHS exposure was directly quantified by measuring nicotine without using a surrogate 
measure such as airborne particulate matter.  
Although exposure misclassification cannot be excluded, in particular for individuals of 
the control group without a workplace badge, the consistency of the results between the 
pre/post model with the exposure-response model suggests that exposure 
misclassification is unlikely to bias our results. Due to limited sample size we could not 
differentiate between the two follow-up examinations in our analysis but this should not 
have caused any bias. Recruitment of eligible participants was unexpectedly tedious as 
restaurant owners were worried about financial losses caused by the smoking ban, a 
concern that was shown to be baseless (Schulz et al. 2012). The exposed control group 
was younger, physically more active and reported more asthma. This might have 
influenced the results. However, they are unlikely to explain the full pattern, since we 
have considered these factors in the exposure-response model. The pre/post model is 
mainly a within-subject comparison where group differences are less relevant. 
Conclusions 
This study indicates that introduction of smoke-free workplaces in hospitality venues 
substantially lowers cardiovascular risk factors in non-smoking hospitality workers and 
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emphasizes the need for authorities worldwide to implement comprehensive policies in 
order to prevent adverse health effects. 
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Figure 1:  Covariate-adjusted Heart Rate Variability parameters at baseline and 
follow-up, Switzerland 2010/2011 
P-values refer to the change in the intervention group relative to the control group.  
SDNN= standard deviation of NN intervals; RMSSD=root mean square of successive 
difference 
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Figure 2:  Covariate-adjusted Pulse Wave Velocity and systolic blood pressure 
at baseline and follow-up, Switzerland 2010/2011 
P-values refer to the change in the intervention group relative to the control group
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Table 1: Study population, Switzerland 2010/2011 
 Intervention group (n=55) Control group (n=23) 
Supplementary 
group (n=14) p-Value‡ 
Female sex 33 (60%) 13 (57%) 11 (79%) 0.37 
Age (years) 42.2 (95% CI: 39.0-45.4) 
31.8 (95% CI: 26.4-
37.2) 
46.8 (95% CI: 41.1-
52.5) 0.001 
BMI (kg/m2) 26.0 (95% CI: 24.9-27.2) 
25.0 (95% CI: 22.7-
27.2) 
25.0 (95% CI: 23.3-
26.7) 0.23 
Overweight (BMI>25) 28 (50.1 %) 11 (47.8 %) 5 (35.7 %) 0.60 
Smoking status 
Never-smokers 40 (72.7 %) 21 (91.3 %) 12 (85.7 %) 
0.15 
Ex-smokers 15 (27.3 %) 2 (8.7 %) 2 (14.3 %) 
Self-reported asthma  4 (7.3 %) 8 (34.8 %) 1 (7.1) 0.01 
Systolic blood pressure (mmHg) 125.0 (95% CI: 121.2-128.7) 
122.3 (95% CI: 115.6-
129.1) 
128.6 (95% CI: 
122.7-134.4) 0.16 
Diastolic blood pressure (mmHg) 81.5 (95% CI: 78.8-84.1) 
77.8 (95% CI: 73.3-
82.3) 
82.3 (95% CI: 77.9-
86.6) 0.24 
Hypertension# 15 (27.3 %) 11 (4.4 %) 4 (28.6 %) 0.07 
  26 
Self-reported diabetes mellitus 0 (0 %) 0 (0 %) 0 (0 %)  
Coronary disease§ 1 (1.8 %) 0 (0 %) 1 (7.1 %) 0.34 
Betablocker intake 6 (10.9 %) 1 (4.4 %) 2 (14.3 %) 0.56 
Allergic* 38 (69.1 %) 16 (69.6 %) 6 (42.9 %) 0.30 
Self-reported physical activity† 19 (34.6 %) 16 (69.6 %) 10 (71.4 %) 0.02 
Average workload (%) 93.8 (n=55) 100.0 (n=7) 84.3 (n=14) 0.20 
Type of workplace 
bar 5 (9.1 %) 2 (88.7 %) 0 (0 %) 
0.007 
café 18 (32.7 %) 0 (0 %) 0 (0 %) 
restaurant 32 (58.2 %) 5 (21.7 %) 14 (100 %) 
other 0 (0 %) 16 (69.6 %) 0 (0 %) 
Pre-ban workplace exposure (cigarette 
equivalents/day) 
2.56 (95% CI: 1.70-
3.44) 
2.07 (95% CI: 0.96-
3.18) 
0.12 (95% CI: 0.03-
0.21)  
Post-ban workplace exposure (cigarette 
equivalents/day) 
0.16 (95% CI: 0.13-
0.20) 
1.59 (95% CI: 0.67-
2.50) NA  
Values shown are arithmetic means at baseline except where indicated 
‡ Kruskal Wallis Test for numerical data, Chi square for proportion 
# defined as positive if diastolic blood pressure>90 mmHg OR systolic blood pressure>140 mmHg 
§ defined as: has taken medication for coronary heart disease during the past 7d 
*reacted positively to at least one skin prick test 
†defined as:  answered yes to: do you sweat at least once/week due to physical activity? 
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Table 2: Heart Rate Variability and Pulse Wave Velocity: pre/post model, Switzerland 2010/2011 
 
  Pre-Ban Post-Ban 
  
Intervention Group Control Group 
p-
Value
# 
Intervention Group Control Group 
p-
Value
‡ 
  
n Geometric Mean (95% CI) n 
Geometric Mean 
(95% CI) 
 
n Geometric Mean (95% CI) n 
Geometric Mean 
(95% CI) 
 
SDNN 
[ms]* 
unadjusted 53 42.1 (37.8-47.0) 21 48.0 (37.5-61.5)  84 46.2 (42.3-50.4) 19 41.4 (33.4-51.3)  
adjusted 53 42.4 (38.2-47.1) 21 43.6 (37.0-51.4) 0.79 84 47.6 (43.3-52.2) 19 38.6 (32.3-46.2) 0.02 
RMSSD 
[ms]* 
unadjusted 53 28.9 (24.9-33.5) 21 36.2 (25.8-50.8)  84 32.5 (28.8-36.7) 19 31.1 (22.2-43.6)  
adjusted 53 30.5 (26.7-34.8) 21 29.7 (24.1-36.7) 0.86 84 34.2 (30.2-38.6) 19 26.7 (21.2-33.4) 0.04 
LF/HF* unadjusted 53 1.5 (1.2-1.9) 21 1.0 (0.6-1.6)  84 1.3 (1.1-1.5) 19 1.3 (0.8-2.0)  
adjusted 53 1.4 (1.1-1.7) 21 1.2 (0.9-1.7) 0.48 84 1.2 (1.0-1.5) 19 1.6 (1.2-2.3) 0.01 
HF 
[ms2]* unadjusted 53 341.4 (240.8-483.8) 21 
556.3 (265.3-
1166.3)  84 
450.4 (342.7-
591.9) 19 377.8 (179.3-796.2)  
adjusted 53 376 (280-505) 21 362 (226-582) 0.92 84 514 (390-677) 19 258 (155-430) 0.01 
LF [ms2]* unadjusted 53 522.6 (408.7-668.2) 21 555.9 (336.5-918.2)  84 
558.1 (461.7-
674.7) 19 
458.8 (287.2- 
732.7)  
  28 
adjusted 53 535 (424-674) 21 444 (310-636) 0.39 84 605 (494-741) 19 395 (266-588) 0.28 
Total 
Power 
[ms2]* 
unadjusted 53 1797.2 (1439.4-2243.9) 21 
2348.0 (1399.6-
3939.0)  84 
2188.8 (1832.1-
2614.9) 19 
1739.1 (1118.8-
2703.2)  
adjusted 53 1807 (1454-2247) 21 1951 (1387-2745) 0.73 84 2323 (1915-2819) 19 1517 (1042-2207) 0.02 
PWV 
[m/s]** 
unadjusted 52 11.2 (10.8-11.6) 19 9.8 (8.9-10.8)  83 10.8 (10.5-11.1) 18 9.8 (9.2-10.5)  
adjusted 52 11.1 (10.8-11.4) 19 10.5 (10.1-11.0) 0.03 83 10.8 (10.5-11.1) 18 10.5 (10.0-11.0) 0.12 
Systolic 
blood 
pressure 
[mmHg]§ 
unadjusted 55 124.3 (120.7-127.9) 23 121.3 (114.7-128.4)  85 
123.4 (120.5-
126.4) 19 124.3 (119.8-128.9)  
adjusted 55 124.1 (120.7-127.5) 23 125.9 (120.4-131.4) 0.90 85 
122.8 (119.5-
126.1) 19 128.3 (122.3-134.3) 0.13 
*Adjusted for age, sex, bmi and season 
**Adjusted for age, sex, bmi, systolic blood pressure, circadian rhythm and season 
§Adjusted for age, sex, bmi, season and asthma 
#Covariate adjusted p-value for the baseline difference according to the mixed linear model 
‡Covariate adjusted p-value for the intervention effect based on the interaction term of the mixed linear model 
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Table 3: Heart Rate Variability and Pulse Wave Velocity: Exposure-Response model, Switzerland 2010/2011 
 
 Coefficient# (95% CI) p-Value Age coefficient‡ (95% CI) p-Value 
SDNN* 1.8 (-0.1 to 3.8) 0.069 -1.5 (-2.1 to -0.9) <0.001 
RMSSD* 2.3 (0.2 to 4.4) 0.031 -2.6 (-3.4 to -1.9) <0.001 
LF/HF* -5.7 (-9.1 to -2.4) 0.001 3.2 (2.1 to 4.4) <0.001 
HF* 5.7 (0.9 to 10.2) 0.020 -5.9 (-7.5 to -4.2) <0.001 
LF* 0.6 (-4.1 to 5.1) 0.802 -2.9 (-4.2 to -1.7) <0.001 
Total Power* 4.1 (0.0 to 8.0) 0.051 -3.0 (-4.1 to -1.8) <0.001 
PWV** -0.72 (-0.40 to -1.05) <0.001 0.69 (0.54 to 0.85) <0.001 
Systolic 
blood 
pressure*** 
-0.07 (-0.32 to 0.47) 0.722 0.28 (0.13 to 0.43) <0.001 
#change in % per unit decrease in cigarette equivalents 
‡change in %  per 1y increase in age 
*adjusted for age, sex, bmi and season 
**adjusted for age, sex, bmi, season, systolic blood pressure and circadian rhythm  
***Adjusted for age, sex, bmi, season and asthma 
 
